Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Cancer Survivorship Issues: A Survey of Patients in India.AIIMS Study (CANSURVIVE) (CANSURVIVE)

11 juillet 2012 mis à jour par: Bidhu Kalyan Mohanti, All India Institute of Medical Sciences, New Delhi

The purpose of this study is to assess the various aspects of life in the cancer survivors in India. Cancer survivor is defined as "an individual diagnosed with cancer and who has survived the disease and treatment, and for the rest of his/her life".

Cancer survivors are at increased risk of developing various physical and psychosocial conditions, which require to be identified and attended within the cancer care system.

Survivorship research is seen as addressing the medical, functional, and health related issues of individuals diagnosed with cancer, as well as that of their families.

Aperçu de l'étude

Statut

Inconnue

Les conditions

Description détaillée

It is estimated that approximately 25 million people are living as cancer survivors worldwide. The cancer survivors are those individuals who live beyond a cancer diagnosis and its therapy. Within the existing health care system, the cancer care models are largely focused on diagnostic methods, treatment aspects, cure, and disease failure and survival rates. There is very little research and intervention approaches for the after-effects of cancer diagnosis and treatments for an individual cancer patient. Cancer survivors are at increased risk of developing various physical and psychosocial conditions, which require to be identified and attended within the cancer care system. In the developing countries like India, the cancer cure rates are improving due to improvements in comprehensive diagnostic and treatment strategies. Cancer survivorship research will be valuable to enhance our understanding and care approaches to these vulnerable individuals in our society. There is lack of evaluation tools which can completely fit to assess all issues such as physical, social, financial, mental aspects of a cancer survivor.

Hence the investigators of this observational study have prepared an empirical cancer survivorship questionnaire (CSQ) which will document the patient's disease and treatment details and obtain subjective responses from the patient(and/or family care giver) related to the physical, functional, social, economic and mental aspects of daily living of a cancer survivor. In order to assess the mental status of the survivors, the investigators have also included the widely used and internationally accepted MINI (Mini-international neuropsychiatry interview) version along with the CSQ in this survey. Researchers and clinicians working in non-profit and academic setting such as this institution are allowed to make copies of this MINI questionnaire for the purpose of clinical and research use. For the present study, MINI version is suitably modified to exclude the items which are already in the CSQ, and certain items are reframed for the socio-cultural requirement. Both the CSQ (45 items) and MINI-modified (13 items) will be applied simultaneously in this survey as a direct face to face response documentation from the patient (cancer survivor), along with his/her family member. Patients will be chosen for this cross-sectional survey during the follow-up visit to a cancer clinic of this hospital, at least 3 months after the completion of cancer diagnosis and therapy. Each participant is expected to complete the survey at the first encounter, however, a provision is made to report any missing information at later visit.

An interim analysis will be carried out after the survey of first 50 patients to observe the trends in the findings. However, this will not impact the further accrual, except for making some changes in the survey parameters if at all needed.

Type d'étude

Observationnel

Inscription (Anticipé)

200

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Delhi
      • New Delhi, Delhi, Inde, 110029
        • Recrutement
        • All India Institute of Medical Sciences Dr.B.R.A.Institute Rotary Cancer Hospital
        • Contact:
        • Contact:
        • Chercheur principal:
          • BIDHU K MOHANTI, MD

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 75 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

This study will evaluate the cancer patients visiting Dr BRAIRCH,AIIMS,New Delhi,India after a cancer diagnosis and the cancer treatments have been completed.

The patients will be entered into this study(survey) during the follow up visits to the clinic.

Patients will be evaluated and assessed for their cancer survivorship issues on the basis of a questionnaire (CSQ) developed by the investigators after the literature review. The mental status of the survivors is assessed by a MINI- international neuro-psychiatric interview, suitably modified to incorporate the CSQ in this survey.

La description

Inclusion Criteria:

  • Patients who were treated with curative intent and are on hospital follow up visit.
  • Patients aged above 18 years and of both sexes.
  • Patients who have no evidence of disease at the time of collecting information.
  • Patients or family carers who are able to comprehend and communicate.
  • Cancer diagnosed and treated at AIIMS, at least 3 months before entry into the study.

Exclusion Criteria:

  • Patients who refuse to provide informed consent for this study.
  • Patients treated for cancer outside AIIMS.
  • Patients who have recurrence or disease failure for which they are or are not receiving salvage therapy.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Adult Cancer Survivors

Intervention:

Behavioural:

Questionnaires for patient/family caregiver interview

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
To study the cancer survivorship experience(as binary responses)
Délai: 1 year
Behavioral: Questionnaires and medical records. The cancer survivors' physical, social, economic and psychological issues will be assessed as verbal response.The survey questionnaires will document the sequelae of cancer and its treatment during the face to face interview and by collecting information from the individual cancer survivor's medical records
1 year
To assess the mental status of cancer survivors
Délai: 1 year
Behavioral:MINI-international neuro-psychiatric questionnaire(modified for local use)
1 year

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
To identify the differences if any, in the cancer survivorship issues by age(Less than 50 or greater than 50 years)
Délai: up to 6 months after patient accrual
This cancer survivorship survey will include adult cancer survivors post-therapy. Survivors of various neoplasms will be accrued for this survey.
up to 6 months after patient accrual
To define follow up care for cancer survivors in India.
Délai: up to 6 months after patient accrual

This survey of 200 adult cancer survivors will analyse various issues-physical, social, psychological and economic which adversely impact the life of cancer survivors in India.

This analysis will help in evolving a feasible approach towards implementation of follow up care practice for cancer survivors.

up to 6 months after patient accrual

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chaise d'étude: BIDHU K MOHANTI, MD, All India Institute of Medical Sciences, New Delhi
  • Directeur d'études: Jaspreet Kaur, MD, All India Institute of Medical Sciences, New Delhi
  • Directeur d'études: Sudhir K Khandelwal, MD, All India Institute of Medical Sciences, New Delhi
  • Directeur d'études: Ravindra M Pandey, PhD, All India Institute of Medical Sciences, New Delhi

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude

1 janvier 2011

Achèvement primaire (Anticipé)

1 juillet 2013

Achèvement de l'étude (Anticipé)

1 décembre 2013

Dates d'inscription aux études

Première soumission

24 février 2011

Première soumission répondant aux critères de contrôle qualité

24 février 2011

Première publication (Estimation)

25 février 2011

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Estimation)

12 juillet 2012

Dernière mise à jour soumise répondant aux critères de contrôle qualité

11 juillet 2012

Dernière vérification

1 juillet 2012

Plus d'information

Termes liés à cette étude

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

3
S'abonner